Proceedings of Anticancer Research

  • Online ISSN: 2208-3553
  • Print ISSN: 2208-3545

Proceedings of Anticancer Research (PAR) is an international peer-reviewed and open access journal, which is devoted to the rapid publication of high-quality original articles, reviews, case reports, short communication and letters on all aspects of experimental and clinical oncology.

The covered topics include, but are not limited to: cellular research and bio-markers, identification of bio-targets and agents with novel mechanisms of action, preventative and integrated treatments for cancer patients, radiation and surgery, palliative care, patient adherence, quality of life, satisfaction, and anticancer medicine, anticancer agents, novel therapies in development, cancer management, biomarkers, diagnostics, clinical trials, treatment guidelines.

 

Current Issue
Vol 6 No 3 (2022)
Published on May 20, 2022
Proceedings of Anticancer Research

Click Here to Download Full Issue

Progress in the Use of Natural Products for the Treatment of Lung Cancer

Song Teng, Zhuoxuan Liang, Tong Lyu, Yuntao Yang, Mengying Gou, Xiaoqiong He
DOI: 10.26689/par.v6i3.3727

Treatment of Melanoma: Current Status and Prospects

Zhiyou Ye
DOI: 10.26689/par.v6i3.3875

Experience in Treating Viral Myocarditis with Master Lei’s Huoxue Decoction

Guoxing Sun, Hong Fan
DOI: 10.26689/par.v6i3.3882

Research Progress in the Application of Lycium Barbarum Polysaccharide in Ophthalmic Diseases

Yanna Lin, Huiqin Wu
DOI: 10.26689/par.v6i3.3885

Lei Genping’s Experience in Treating Recurrent Urinary Tract Infection

Lin Xia, Genping Lei
DOI: 10.26689/par.v6i3.3886

A Summary of Lei Genping’s Experience in the Treatment of Chronic Nephritis

Yue Zhang, Genping Lei
DOI: 10.26689/par.v6i3.3884

Are M1 and M2 macrophages Effectual Players in Pathological Conditions?

Elham Abdollahi, Nafiseh Saghafi, Malihe Hasanzade
DOI: 10.26689/par.v6i3.3962

Research Progress of Traditional Chinese and Western Medicine in Hyperthyroid Heart Disease

Shuyu Li, Mingjun Zhao
DOI: 10.26689/par.v6i3.3984

Clinical Efficacy of Lenalidomide Combined with Cyclophosphamide and Dexamethasone in the Treatment of Multiple Myeloma

Yudi Miao
DOI: 10.26689/par.v6i3.3998

Inhibition of RNaseH2A Induces Fas-Regulated Programmed Cell Death in Hepatoma Cells

Xiaowei Chang, Yu Cai, Pu Yan, Wujun Li
DOI: 10.26689/par.v6i3.4011

A Study on the Effectiveness of Decitabine Combined with a Half-Dose Priming Regimen in the Treatment of Elderly Patients with Acute Myeloid Leukemia

Ying Gao, Lan Li, Xingxing Hu, Yudi Miao
DOI: 10.26689/par.v6i3.3999

Clinical Value of Peripheral Blood Circulating Tumor Cells and Cell-Free DNA Combined Detection in Triple-Negative Breast Cancer

Jirui Sun, Shuangqui Ma, Hong Chen, Huijuan Geng, Jinku Zhang
DOI: 10.26689/par.v6i3.4019